Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors
NCT05649683
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL:
Evaluation of cytokine production
Sponsor
Centre Hospitalier Universitaire de Nice